All
FDA Approves Epkinly for Relapsed, Refractory Follicular Lymphoma
The Food and Drug Administration approved Epkinly, a bispecific T-cell engager, for certain patients with follicular lymphoma.
Imfinzi Shows Promising Results in Muscle-Invasive Bladder Cancer
Patients saw improved event-free survival and overall survival with presurgical Imfinzi and chemotherapy followed by surgery and postsurgical Imfinzi.
Having a Cancer Community on Social Media Can Be Healing
Talking about the good, bad and ugly aspects of cancer on social media is “the most healing part of this community,” a survivor said.
Surviving Acute Myeloid Leukemia Has Finally Sunk In
Being able to live independently and enjoy life’s beauty summon feelings of gratitude and euphoria more often now.
Side Effects to Monitor During HER2-Positive Breast Cancer Treatment
One expert explained the common side effects at every line of treatment for metastatic HER2-positive breast cancer during the CURE® Educated Patient® Metastatic Breast Cancer Summit.
A Path After Cancer Doesn't Have to Be Linear
I used to think that having lung cancer canceled all of my life's plans, but I realized I shouldn't give it that much power.
MRD Status Associated With Event-Free Survival in T-Lymphoblastic Lymphoma
In children with T-lymphoblastic lymphoma, having an MRD status of less than 0.1% may lead to more time without their cancer worsening or coming back.
Imdelltra for Small Cell Lung Cancer Addresses Key Unmet Needs
Imdelltra has offered a new treatment option for patients with small cell lung cancer that “is not like anything we’ve ever seen before,” an expert said.
My New Image After Testicular Cancer
After testicular cancer hindered my self-image and identity, I decided to create a five-point system to help me achieve a successful future.
Retevmo Approval the Beginning of Targeted Therapy for RET-Mutant Childhood Cancer
An expert discusses the recent approval for Retevmo for RET-positive pediatric thyroid cancer and ongoing research for this patient population.
My Community of Support During Multiple Cancers
My oncologist said that having a supportive community during cancer is just as important as treatment and I could not agree more — it makes me thankful.
Dato-DXd Falls Short in Overall NSCLC Population, Shows Benefit in Non-Squamous Disease
Dato-DXd did not improve survival in the overall population with non-small cell lung cancer but did boost outcomes in patients with non-squamous disease.
Expectations for Postsurgical Treatments in Kidney Cancer
For patients with kidney cancer undergoing postsurgical treatments, it’s key to understand how immunotherapy works and what side effects to look for.
Fighting Multiple Myeloma With Feng Shui
A beautiful tapestry reminded me to stay positive, even during a challenging time with cancer.
FDA to Review Subcutaneous Rybrevant for NSCLC Treatment
A Biologics License Application has been filed for the subcutaneous administration of Rybrevant for some patients with non-small cell lung cancer.
Negative Cancer Care Experiences Shaped My Life
My health care team went back and forth on whether spots on my liver were cancerous, and that put me on an emotional rollercoaster.
Shifting the Spotlight to Cancer Vaccines
With many groundbreaking cancer therapies on the horizon, it's also time to focus on up and coming cancer vaccines.
Cancer and the Question of Faith
In the 2024 CURE Summer issue, we focused on a facet of cancer: the question of faith.
Finding Support and Hope After a Rare Cancer Diagnosis
Participating in research and leaning on advocacy organizations helped me through my rare cancer diagnosis.
How Targeted Therapies Changed Lung Cancer Treatment
One expert explains why “the future of precision medicine” has arrived in lung cancer at the CURE® Educated Patient® Lung Cancer Summit.
Having 'Dignity and Respect' During Cancer
LGBTQI+ patients with cancer are encouraged to seek positive relationships with care teams despite possible histories of minority stress.
FDA Approves Krazati Plus Erbitux for KRAS-Mutant CRC
The Food and Drug Administration approved Krazati plus Erbitux for pretreated KRAS G12C-mutant colorectal cancer.
The Importance of Having a Cancer Community
Being a part of the cancer community means meeting new people, forming personal friendships and fostering those connections for others.
Don Omar Announces Being Cancer Free, ‘General Hospital’ Star Opens Up About Cancer and More
From Don Omar announcing being cancer free to “General Hospital” star John York talking about treatment for his two cancers, here’s what’s going on in the oncology space this week.
A Personalized Approach to Combining Drugs and Surgery for NSCLC
Tumor characteristics are used to determine the best method of combining therapies with surgery for non-small cell lung cancer, according to a presentation at the CURE® Educated Patient® Lung Cancer Summit.
Earlier Calquence Leads to Improved Survival Outcomes in CLL
Patients with chronic lymphocytic leukemia had better survival when treated with Calquence during earlier lines of therapy.
CAR-T Moving to Earlier Availability in Multiple Myeloma
During the CURE® Educated Patient® Multiple Myeloma Summit, one expert explained the push to make CAR-T cell therapy available for patients sooner.
Having a Great Primary Care Doctor During Cancer Made a Difference
My reliable primary care physician was such an important asset in navigating multiple cancers.
Combining Drugs, Radiation Is ‘Practice-Changing’ for Some Lung Cancer Subsets
Radiation plus targeted or immunotherapies could be beneficial for certain patients with lung cancer, and expert said at the CURE® Educated Patient® Lung Cancer Summit.
The New Age of Cancer Survivorship
Survivorship, when talking about cancer, is defined not just by the end of treatment, but by the entire journey that follows initial diagnosis.
